Entrada Therapeutics Inc — Financial Statements (NASDAQ:TRDA) | MetaTrader

Open full chart

Nouvelles

Le BPA de Entrada Therapeutics a dépassé les attentes de 0,04$, le CA en dessous des prévisions

Entrada Therapeutics earnings beat by $0.04, revenue fell short of estimates

Arcutis Biotherapeutics, Inc. (ARQT) Surpasses Q4 Earnings and Revenue Estimates

Repligen (RGEN) Tops Q4 Earnings and Revenue Estimates

Earnings Preview: Entrada Therapeutics, Inc. (TRDA) Q4 Earnings Expected to Decline

EyePoint (EYPT) Surges 15.2%: Is This an Indication of Further Gains?

Illumina (ILMN) Tops Q4 Earnings and Revenue Estimates

Techne (TECH) Beats Q2 Earnings and Revenue Estimates

Entrada Therapeutics, Inc. (TRDA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Capricor Therapeutics Stock: A High Risk/High Reward Name (NASDAQ:CAPR)

Entrada fait état de progrès dans les traitements de la DMD et partage son calendrier clinique

Entrada reports progress on DMD treatments, shares clinical timeline